119th Congress
S. 4323
Ensuring Access to Lower-Cost Medicines for Seniors Act
- Introduced
- In committee
- Passed Senate
- Passed House
- To President
- Became law
- Sponsor
- James Lankford(R-OK)
- Introduced
- Apr 16, 2026
- Policy area
- Health
- Committees
- Senate Committee on Finance
- Official text
- Introduced in Senate · Congress.gov page
Cosponsors (2)
Original cosponsors (1)
- Margaret Wood Hassan (D-NH)
Added later (1)
- Michael F. Bennet (D-CO) · Aug 6, 2026
Summary
Summary by the Congressional Research Service· describes the “Introduced in Senate” version
Ensuring Access to Lower-Cost Medicines for Seniors Act
This bill requires prescription drug plans under the Medicare prescription drug benefit to include generic drugs and biosimilars on their formularies.
Specifically, the bill requires plans that use formularies to include generic drugs and biosimilars on the formularies and without any requirements (e.g., prior authorization requirements) that are more restrictive as compared to those for brand-name drugs and biologics. Plans that use cost-sharing tiers must also have specific tiers for generic drugs and biosimilars, in accordance with certain limitations.
Roll-call votes
No recorded votes on this bill.
Actions
- Apr 16, 2026 · Senate
Read twice and referred to the Committee on Finance. - Apr 16, 2026
Introduced in Senate